Home Amgen files application in Europe for expanded use of Kyprolis
 

Keywords :   


Amgen files application in Europe for expanded use of Kyprolis

2015-12-06 03:02:21| Biotech - Topix.net

Amgen submits a Variation to the Marketing Authorization Application to the European Medicines Agency seeking clearance for the use of Kyprolis , in combination with the corticosteroid dexamethasone, in adult multiple myeloma patients who have received at least one prior therapy. The data supporting the application was generated in the Phase 3 ENDEAVOR study that showed patients treated with Kyprolis plus dexamethasone achieved superior progression-free survival compared to patients who received Takeda's Velcade plus dexamethasone were diarrhea, anemia, fatigue, dyspnea , pyrexia and insomnia.

Tags: of application files europe

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.11Eastern North Pacific Tropical Weather Outlook
24.11Atlantic Tropical Weather Outlook
24.11
24.11sobbat DB4R
24.11RC10
24.11 Knicks
24.11 W6S-JP001
24.11SALOMON XLT 150
More »